Grant: Catalyst Grant: Secondary Analysis of Neuroimaging Databases
University of Toronto
$100,000.00
Assessing the Relationship of White Matter Hyperintensities to Neuropsychiatric Symptoms in Patients with Alzheimer's Disease
EF 2013-14
Résumé
Cerebral white matter damage, seen on MRI, are assumed to be ischemic lesions and are very common in aging patients as well as patients with Alzheimer's disease. Neuropsychiatric symptoms are common in all types of dementia. The most common neuropsychiatric symptoms encountered in dementia are delusions, hallucinations, agitation, depression, anxiety, apathy, and irritability. These symptoms are a major source of patients' distress, caregiver burden, and a primary contributor to institutionalization. Moreover, while psychotropic drugs may alleviate certain neuropsychiatric symptoms, some have severe effects including a 2-3 times increased risk of a cerebrovascular event, including a stroke. There is increasing awareness that changes in white matter can be associated with neurobehavioral changes including some of the neuropsychiatric symptoms listed above. In AD, the relationship between neuropsychiatric symptoms and the extent and location of white matter damage is unknown. Since vascular disease is treatable, a reduction in vascular-related neuropsychiatric symptoms may prevent (or delay) institutionalization thus saving costs to the health care system while improving quality of life for the patient and family.
Programme
Catalyst Grant: Secondary Analysis of Neuroimaging Databases
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
293767
Name
Tartaglia Maria Carmela
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Catalyst Grant: Secondary Analysis of Neuroimaging Databases
Projecttitle
Assessing the Relationship of White Matter Hyperintensities to Neuropsychiatric Symptoms in Patients with Alzheimer's Disease
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Catalyst Grant: Secondary Analysis of Neuroimaging Databases
Keyworddelim
Adni; Alzheimer'S Disease; Imaging; Vascular Disease
Abstract
Cerebral white matter damage, seen on MRI, are assumed to be ischemic lesions and are very common in aging patients as well as patients with Alzheimer's disease. Neuropsychiatric symptoms are common in all types of dementia. The most common neuropsychiatric symptoms encountered in dementia are delusions, hallucinations, agitation, depression, anxiety, apathy, and irritability. These symptoms are a major source of patients' distress, caregiver burden, and a primary contributor to institutionalization. Moreover, while psychotropic drugs may alleviate certain neuropsychiatric symptoms, some have severe effects including a 2-3 times increased risk of a cerebrovascular event, including a stroke. There is increasing awareness that changes in white matter can be associated with neurobehavioral changes including some of the neuropsychiatric symptoms listed above. In AD, the relationship between neuropsychiatric symptoms and the extent and location of white matter damage is unknown. Since vascular disease is treatable, a reduction in vascular-related neuropsychiatric symptoms may prevent (or delay) institutionalization thus saving costs to the health care system while improving quality of life for the patient and family.
Competitiondate
201310
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Tartaglia, Maria Carmela
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $100,000~ $0~